Break-up of nano-particle agglomerates by hydrodynamically limited processes

When dry nano-particulate powders are first added into a liquid, clusters as large as hundreds of microns can be formed. In this study, high shear impellers, such as the sawtooth Ekatomizer and rotor-stator impellers were used to suspend and break-up these agglomerates in a stirred vessel. The high local energy dissipation rates generated by these impeller could slowly break up clusters to sub-micron sizes by an erosional mechanism. In comparison, single and multiple passes through a valve homogeniser could quickly break the nano-particle clusters to sub-micron sizes; single pass operation had the highest breakage efficiency for a given specific energy input. For both equipment types, the rate of fines generation was found to be controlled by the maximum energy dissipation rate. However, the size of the fine aggregates produced was a constant and was not a function of the energy dissipation rate

Modulation of Bone’s Sensitivity to Low-Intensity Vibrations by Acceleration Magnitude, Vibration Duration, and Number of Bouts

Variables defining vibration-based biomechanical treatments were tested by their ability to affect the musculoskeleton in the growing mouse. Duration of a vibration bout, but not variations in vibration intensity or number of vibration bouts per day, was identified as modulator of trabecular bone formation rates. INTRODUCTION: Low-intensity vibrations (LIV) may enhance musculoskeletal properties, but little is known regarding the role that individual LIV variables play. We determined whether acceleration magnitude and/or the number and duration of daily loading bouts may modulate LIV efficacy. METHODS: LIV was applied to 8-week-old mice at either 0.3 g or 0.6 g for three weeks; the number of daily bouts was one, two, or four, and the duration of a single bout was 15, 30, or 60 min. A frequency of 45 Hz was used throughout. RESULTS: LIV induced tibial cortical surface strains in 4-month-old mice of approximately 10 με at 0.3 g and 30 με at 0.6 g. In trabecular bone of the proximal tibial metaphysis, all single daily bout signal combinations with the exception of a single 15 min daily bout at 0.3 g (i.e., single bouts of 30 and 60 min at 0.3 g and 15 and 30 min at 0.6 g) produced greater bone formation rates (BFR/BS) than in controls. Across all signal combinations, 30 and 60 min bouts were significantly more effective than 15 min bouts in raising BFR/BS above control levels. Increasing the number of daily bouts or partitioning a single daily bout into several shorter bouts did not potentiate efficacy and in some instances led to BFR/BS that was not significantly different from those in controls. Bone chemical and muscle properties were similar across all groups. CONCLUSIONS: These data may provide a basis towards optimization of LIV efficacy and indicate that in the growing mouse skeleton, increasing bout duration from 15 to 30 or 60 min positively influences BFR/BS

Additional file 1: Table S1. of A retrospective paired study: efficacy and toxicity of nimotuzumab versus cisplatin concurrent with radiotherapy in nasopharyngeal carcinoma

Prognostic factors for overall survival (Univariate) (N = 104). Table S2. Prognostic factors for overall survival (multivariable) (N = 104). Table S3. Toxicities in stage III and IV patients with h-R3/RT and CDDP/RT (N = 78). Table S4. Assignment expressions for factors in the table of patients’ characteristics. Table S5. Patients’ compliance (104 cases). Table S6. Neoadjuvant chemotherapy was recommended by NCCN guidelines of Head and Neck Cancer. Table S7. General information for all 302 patients of CDDP/RT and h-R3/RT group. Table S8. Prognostic factors for Overall Survival of all 302 patients (Univariate). Table S9. Prognostic factors for Overall Survival of all 302 patients (Multivariable). (ZIP 437 kb

Additional file 2: Figure S1. of A retrospective paired study: efficacy and toxicity of nimotuzumab versus cisplatin concurrent with radiotherapy in nasopharyngeal carcinoma

Overall survival of stage II patients who received h-R3/RT or CDDP/RT. Figure S2. Overall survival of patients aged more than 60 years old who received h-R3/RT or CDDP/RT. Figure S3. Overall survival in stage III and IV patients with h-R3/RT and CDDP/RT. (ZIP 12 kb

DS_10.1177_0022034518781509 – Supplemental material for Overexpressed Sirt1 in MSCs Promotes Dentin Formation in Bmi1-Deficient Mice

<p>Supplemental material, DS_10.1177_0022034518781509 for Overexpressed Sirt1 in MSCs Promotes Dentin Formation in Bmi1-Deficient Mice by H. Wang, C. Lv, Y. Gu, Q. Li, L. Xie, H. Zhang, D. Miao and W. Sun in Journal of Dental Research</p